IP Library Assignment 030804/0836
Patent Assignment
Reel/Frame 030804/0836

Assignment of Assignor's Interest

Recorded: 2013-07-16 Pages: 8
Assignor
ABBOTT GMBH & CO KG
Executed: 2012-11-01
Assignee
ABBVIE DEUTSCHLAND GMBH & CO KG
MAX-PLANCK-RING 2A, WIESBADEN, 65205, GERMANY
Covered Properties (63)
Methods of Preparation of Recombinant Forms of Human Beta-Amyloid Protein and Uses of These Proteins
Patent: 8,263,558 →
Application: 11/574,844 →
Publication: US 2009/0214515
Amyloid-Beta Globulomer Antibodies
Patent: 8,497,072 →
Application: 11/574,847 →
Publication: US 2009/0238831
Anti-ABeta Globulomer 5F7 Antibodies
Patent: 8,691,224 →
Application: 11/574,876 →
Publication: US 2009/0191190
Dosage forms for the delivery of drugs of abuse and related methods
Application: 11/625,705 →
Publication: US 2007/0190142
Formulations of Nonopioid and Confined Opioid Analgesics
Application: 11/780,625 →
Publication: US 2009/0022798
Screening Method, Process for Purifying of Non-Diffusible A-Beta Oligomers, Selective Antibodies Against Said Non-Diffusible a-Beta Oligomers and a Process for Manufacturing of Said Antibodies
Application: 11/885,362 →
Publication: US 2009/0035295
Substituted Oxindole Derivatives, Medicaments Containing the Latter and Use Thereof
Patent: 8,129,389 →
Application: 11/886,729 →
Publication: US 2009/0186904
Substituted Oxindole Derivatives, Drugs Containing Said Derivatives and the Use Thereof
Patent: 7,803,834 →
Application: 11/886,730 →
Publication: US 2009/0163492
Substituted Oxindole Derivatives, Medicaments Containing the Latter and Use Thereof
Patent: 8,202,870 →
Application: 11/886,731 →
Publication: US 2009/0215790
Neutralizing Monoclonal Antibodies Against the Nogo-66 Receptor (Ngr)
Patent: 7,906,120 →
Application: 11/943,770 →
Publication: US 2008/0279859
Abeta Conformer Selective Anti-Abeta Globulomer Monoclonal Antibodies
Patent: 8,455,626 →
Application: 11/945,124 →
Publication: US 2009/0035307
Carboxamide Compounds and Their Use as Calpain Inhibitors
Patent: 8,436,034 →
Application: 11/990,652 →
Publication: US 2010/0298326
5-Ring Heteroaromatic compounds and their use as binding partners for 5-ht5 receptors
Patent: 8,921,406 →
Application: 11/990,731 →
Publication: US 2011/0207788
Heterocyclic Compounds and Their Use as Binding Partners for 5-HT5 Receptors
Patent: 8,686,002 →
Application: 11/990,822 →
Publication: US 2010/0041698
Hetaryl-substituted guanidine compounds and use thereof as binding partners for 5-ht5-receptors
Patent: 9,296,697 →
Application: 11/990,937 →
Publication: US 2010/0184787
Binding Domains of Proteins of the Repulsive Guidance Molecule (Rgm) Protein Family and Functional Fragments Thereof, and Their Use
Patent: 8,906,864 →
Application: 11/992,720 →
Publication: US 2009/0297527
Itraconazole Compositions with Improved Bioavailability
Patent: 8,486,456 →
Application: 11/997,256 →
Publication: US 2009/0214656
Carboxamide Compounds and Their Use as Calpain Inhibitors
Patent: 7,728,012 →
Application: 12/070,941 →
Publication: US 2008/0234329
Carboxamide Compounds and Their Use as Calpain Inhibitors
Patent: 7,799,809 →
Application: 12/072,065 →
Publication: US 2008/0234330
Substituted Oxindole Derivatives, Medicaments Containing Said Derivatives and Use Thereof
Patent: 8,044,079 →
Application: 12/095,594 →
Publication: US 2010/0273766
Heterocyclic Compounds as Positive Modulators of Metabotropic Glutamate Receptor 2 (MGLU2 Receptor)
Patent: 9,242,933 →
Application: 12/126,174 →
Publication: US 2008/0300260
Solid Dispersion Product Containing N-Aryl Urea-Based Compound
Application: 12/253,499 →
Publication: US 2009/0143423
Benzenesulfonanilide Compounds Suitable for Treating Disorders That Respond to Modulation of the Serotonin 5-HT6 Receptor
Patent: 7,790,727 →
Application: 12/262,455 →
Publication: US 2009/0131452
Process for Producing a Solid Dispersion of an Active Ingredient
Application: 12/279,385 →
Publication: US 2009/0302493
Process for Producing a Solid Dispersion of an Active Ingredient
Application: 12/279,415 →
Publication: US 2009/0311414
Aryloxyethylamine Compounds Suitable for Treating Disorders That Respond to Modulation of the Dopamine D3 Receptor
Patent: 8,383,641 →
Application: 12/296,739 →
Publication: US 2009/0143383
Heterocyclic Compounds Suitable for Treating Disorders That Respond to Modulation of the Serotonin 5HT6 Receptor
Patent: 8,497,273 →
Application: 12/297,328 →
Publication: US 2010/0048582
Heterocyclic Arylsulphones Suitable for Treating Disorders That Respond to Modulation of the Serotonin 5HT6 Receptor
Patent: 8,642,642 →
Application: 12/297,350 →
Publication: US 2009/0306175
Production of Pharmaceutical Dosage Forms Enveloped by a Shrinkable Film
Application: 12/301,558 →
Publication: US 2009/0274731
Pharmaceutically Acceptable Solubilizing Composition and Pharmaceutical Dosage Form Containing Same
Patent: 9,078,921 →
Application: 12/305,870 →
Publication: US 2010/0247635
Substituted Oxindole Derivatives and Their Use as Vasopressin and/or Oxytocin Receptor Ligands
Patent: 8,431,567 →
Application: 12/438,696 →
Publication: US 2009/0318406
Substituted Benzimidazolone Derivatives, Medicaments Comprising Them and Their Use
Patent: 8,119,676 →
Application: 12/438,712 →
Publication: US 2010/0152168
Heterocyclic Compounds and Their Use as Glycogen Synthase Kinase 3 Inhibitors
Patent: 8,642,598 →
Application: 12/446,233 →
Publication: US 2010/0324042
Pharmaceutical Dosage Form for Oral Administration of Tyrosine Kinase Inhibitor
Application: 12/447,488 →
Publication: US 2010/0143459
Solid Dosage Form with a Film Containing an Active Substance, as Well as Its Method of Production
Patent: 8,673,344 →
Application: 12/447,506 →
Publication: US 2010/0119583
Melt-Processed Imatinib Dosage Form
Patent: 8,841,303 →
Application: 12/447,508 →
Publication: US 2010/0240672
Device and Method for Forming Moulded Bodies from a Mouldable Mass
Patent: 8,568,127 →
Application: 12/514,659 →
Publication: US 2010/0148399
High Power Rotational Cycle Moulding Method and Device
Patent: 8,277,212 →
Application: 12/514,980 →
Publication: US 2010/0072666
Method for the treatment of amyloidoses
Application: 12/529,331 →
Publication: US 2010/0311767
Substituted Oxindole Compounds
Patent: 8,486,931 →
Application: 12/529,542 →
Publication: US 2010/0286165
Azetidin Compounds Suitable for Treating Disorders That Respond to Modulation of the Serotonin 5-HT6 Receptor
Patent: 8,507,469 →
Application: 12/532,406 →
Publication: US 2010/0137280
Quinoline Compounds Suitable for Treating Disorders That Respond to Modulation of the Serotonin 5-HT6 Receptor
Patent: 8,242,102 →
Application: 12/532,407 →
Publication: US 2011/0009380
Quinoline Compounds Suitable for Treating Disorders That Respond to Modulation of the Serotonin-5-HT6 Receptor
Patent: 8,293,913 →
Application: 12/664,394 →
Publication: US 2010/0292271
4-Benzylaminoquinolines, Pharmaceutical Compositions Containing Them, and Their Use in Therapy
Patent: 8,420,670 →
Application: 12/666,629 →
Publication: US 2010/0222346
Preparation of Compositions with Essentially Noncrystalline Embedded Macrolide Antibiotics
Patent: 8,337,733 →
Application: 12/673,230 →
Publication: US 2012/0001361
4-(4-Pyridinyl)-Benzamides and Their Use as Rock Activity Modulators
Patent: 8,445,686 →
Application: 12/675,430 →
Publication: US 2010/0273828
Bone morphogenetic protein (BMP)-binding domains of proteins of the repulsive guidance molecule (RGM) protein family and functional fragments thereof, and use of same
Application: 12/677,054 →
Publication: US 2010/0322948
1,2,4,-Triazin-3,5-Dione Compounds Suitable for Treating Disorders That Respond to Modulation of the Dopamine D3 Receptor
Patent: 8,492,540 →
Application: 12/740,714 →
Publication: US 2010/0311755
Pharmaceutical Dosage Form Comprising a Liquid or Flowable Core Composition
Application: 12/746,474 →
Publication: US 2010/0297223
Carbamate-Substituted Oxindole Derivatives and Use Thereof for the Treatment of Vasopressin-Dependent Diseases
Patent: 8,703,774 →
Application: 12/746,688 →
Publication: US 2011/0065720
Amidomethyl-Substituted Oxindole Derivatives and the Use Thereof for the Treatment of Vasopressin-Dependent Illnesses
Patent: 8,703,775 →
Application: 12/746,700 →
Publication: US 2011/0077253
Substituted Oxindole-Derivatives and the Use Thereof for the Treatment of Vasopressin-Dependent Illnesses
Patent: 8,629,148 →
Application: 12/810,561 →
Publication: US 2011/0105454
NEUTRALIZING MONOCLONAL ANTIBODIES AGAINST THE NOGO-66 RECEPTOR (NgR) AND USES THEREOF
Application: 12/880,333 →
Publication: US 2011/0142845
Formulations of Nonopioid and Confined Opioid Analgesics
Application: 12/984,373 →
Publication: US 2011/0229526
Abeta CONFORMER SELECTIVE ANTI-Abeta GLOBULOMER MONOCLONAL ANTIBODIES
Patent: 8,877,190 →
Application: 13/102,713 →
Publication: US 2011/0212109
Dosage Forms with Improved Bioavailability
Patent: 9,060,936 →
Application: 13/165,398 →
Publication: US 2011/0311595
Benzenesulfonamide Compounds Suitable for Treating Disorders That Respond to Modulation of the Dopamine D3 Receptor
Application: 13/187,885 →
Publication: US 2011/0319421
Monoclonal Antibodies Against Amyloid Beta Protein and Uses Thereof
Application: 13/188,034 →
Publication: US 2011/0287005
Formulation Comprising Fenofibric Acid, a Physiologically Acceptable Salt or Derivative Thereof
Application: 13/216,888 →
Publication: US 2012/0046360
Substituted Oxindole Derivatives, Medicaments Containing Said Derivatives and Use Thereof
Patent: 9,006,276 →
Application: 13/243,166 →
Publication: US 2013/0029966
Substituted Benzimidazolone Derivatives, Medicaments Comprising Them and Their Use
Patent: 8,791,148 →
Application: 13/302,194 →
Publication: US 2012/0172335
Substituted Oxindole Derivatives, Medicaments Containing the Latter and Use Thereof
Application: 13/361,488 →
Publication: US 2012/0136001
Quinoline Compounds Suitable for Treating Disorders That Respond to Modulation of the Serotonin-5-HT6 Receptor
Patent: 8,440,694 →
Application: 13/613,344 →
Publication: US 2013/0005703
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Feb 21, 2007
From: BREITENBACH, JORG; LANDER, UTE; ROSENBERG, JORG; MAEGERLEIN, MARKUS
To: ABBOTT GMBH & CO. KG
Reel/Frame 018915/0581 →
Assignment of Assignor's Interest Dec 10, 2007
From: ROSENBERG, JOERG; WOEHRLE, GERD H.; KESSLER, THOMAS Y.; BREITENBACH, JOERG
To: ABBOTT GMBH & CO. KG
Reel/Frame 020222/0321 →
Assignment of Assignor's Interest Apr 17, 2008
From: HILLEN, HEINZ; STRIEBINGER, ANDREAS; KELLER, PATRICK; BARGHORN, STEFAN
To: ABBOTT GMBH & CO. KG
Reel/Frame 020870/0020 →
Assignment of Assignor's Interest May 27, 2008
From: KLING, ANDREAS; HORNBERGER, WILFRIED; MACK, HELMUT; MOELLER, ACHIM
To: ABBOTT GMBH & CO. KG
Reel/Frame 021037/0204 →
Assignment of Assignor's Interest Jul 1, 2008
From: BERNDL, GUNTHER; DEGENHARDT, MATTHIAS; MAEGERLEIN, MARKUS
To: ABBOTT GMBH & CO. KG
Reel/Frame 021176/0287 →
Assignment of Assignor's Interest Jul 2, 2008
From: MEZLER, MARIO; MOELLER, ACHIM; MUELLER, REINHOLD; MUELLER, BERNHARD K.
To: ABBOTT LABORATORIES
Reel/Frame 021186/0576 →
Assignment of Assignor's Interest Aug 5, 2008
From: OOST, THORSTEN; LUBISCH, WILFRIED; WERNET, WOLFGANG; HORNBERGER, WILFRIED
To: ABBOTT GMBH & CO. KG
Reel/Frame 021347/0971 →
Assignment of Assignor's Interest Aug 5, 2008
From: LUBISCH, WILFRIED; OOST, THORSTEN; WERNET, WOLFGANG; HORNBERGER, WILFRIED
To: ABBOTT GMBH & CO. KG
Reel/Frame 021347/0966 →
Assignment of Assignor's Interest Aug 5, 2008
From: LUBISCH, WILFRIED; OOST, THORSTEN; WERNET, WOLFGANG; HORNBERGER, WILFRIED
To: ABBOTT GMBH & CO. KG
Reel/Frame 021347/0930 →
Assignment of Assignor's Interest Aug 5, 2008
From: KLING, ANDREAS; HORNBERGER, WILFRIED; MACK, HELMUT; MOELLER, ACHIM
To: ABBOTT GMBH & CO. KG
Reel/Frame 021347/0987 →
Assignment of Assignor's Interest Sep 30, 2008
From: HILLEN, HEINZ; BARGHORN, STEFAN; EBERT, ULRICH M.
To: ABBOTT GMBH & CO. KG
Reel/Frame 021611/0382 →
Assignment of Assignor's Interest Sep 30, 2008
From: HOLZMAN, THOMAS F.; HARLAN, JOHN E.; EDALJI, ROHINTON; YU, LIPING
To: ABBOTT LABORATORIES
Reel/Frame 021610/0852 →
Assignment of Assignor's Interest Oct 16, 2008
From: BARGHORN, STEFAN; HILLEN, HEINZ; STRIEBINGER, ANDREAS R.; EBERT, ULRICH
To: ABBOTT GMBH & CO. KG
Reel/Frame 021692/0894 →
Assignment of Assignor's Interest Oct 16, 2008
From: LABKOVSKY, BORIS
To: ABBOTT LABORATORIES
Reel/Frame 021692/0646 →
Assignment of Assignor's Interest Dec 31, 2008
From: HILLEN, HEINZ; BARGHORN, STEFAN; EBERT, ULRICH M.; STIEBINGER, ANDREAS R.
To: ABBOTT GMBH & CO. KG
Reel/Frame 022046/0955 →
Assignment of Assignor's Interest Dec 31, 2008
From: LABKOVSKY, BORIS
To: ABBOTT LABORATORIES
Reel/Frame 022046/0918 →
Assignment of Assignor's Interest Feb 16, 2009
From: DISPERSYN, GERRIT
To: BARRIER THERAPEUTICS, INC.
Reel/Frame 022260/0574 →
Assignment of Assignor's Interest Feb 25, 2009
From: LABKOVSKY, BORIS
To: ABBOTT LABORATORIES
Reel/Frame 022307/0606 →
Assignment of Assignor's Interest Feb 25, 2009
From: BARGHORN, STEFAN; HILLEN, HEINZ; STRIEBINGER, ANDREAS R.; KELLER, PATRICK
To: ABBOTT GMBH & CO. KG
Reel/Frame 022307/0692 →
Corrective Assignment to Correct the <Docket Number> Previously Recorded on Reel 022307 Frame 0606. Assignor(S) Hereby Confirms the <8120USO1> to <8126USO1>. Feb 26, 2009
From: LABKOVSKY, BORIS
To: ABBOTT LABORATORIES
Reel/Frame 022316/0925 →
Assignment of Assignor's Interest Mar 9, 2009
From: NETZ, ASTRID; KLING, ANDREAS; OCHSE, MICHAEL; LANGE, UDO
To: ABBOTT GMBH & CO. KG
Reel/Frame 022367/0346 →
Assignment of Assignor's Interest Nov 11, 2009
From: AMBERG, WILHELM; NETZ, ASTRID; KLING, ANDREAS; OCHSE, MICHAEL
To: ABBOTT GMBH & CO. KG
Reel/Frame 023502/0350 →
Assignment of Assignor's Interest Nov 17, 2009
From: AMBERG, WILHELM; NETZ, ASTRID; KLING, ANDREAS; OCHSE, MICHAEL
To: ABBOTT GMBH & CO. KG
Reel/Frame 023531/0938 →
Assignment of Assignor's Interest Aug 9, 2010
From: KLING, ANDREAS; HORNBERGER, WILFRIED; MACK, HELMUT; MOELLER, ACHIM
To: ABBOTT GMBH & CO. KG
Reel/Frame 024809/0022 →
Assignment of Assignor's Interest Feb 3, 2011
From: ABBOTT LABORATORIES
To: ABBOTT GMBH & CO. KG
Reel/Frame 025742/0958 →